Literature DB >> 17534408

QUASI analysis of the HIV-1 envelope sequences in the Los Alamos National Laboratory HIV sequence database: pattern and distribution of positive selection sites and their frequencies over years.

Binhua Liang1, Ma Luo, T Blake Ball, Francis A Plummer.   

Abstract

The envelope (env) protein of human immunodeficiency virus type 1 (HIV-1) plays a crucial role in virus entry and is a central target for HIV vaccine design. Using the QUASI program, we analyzed the conserved regions of all currently available env sequences in the Los Alamos National Laboratory HIV Sequence Database and identified positive selection (PS) sites that are likely to be restricted by host immune responses. We found that PS sites are dispersed across conserved regions of env sequence, and that the C3, C4, and C5 regions were the most targeted. Several regions were identified as being PS free and were mainly distributed in the C1 and C2 regions. When comparing individual QUASI PS site frequencies across clades and geographical regions with the overall frequency of the entire env database, the env sequences from North America showed significantly lower PS site frequency, while those from Asia were significantly higher using Student's t test. The QUASI PS site frequency of env proteins from viruses isolated from different years showed that the PS site frequencies of the env population increased over time. Our study provides an overview of PS sites across the conserved regions of HIV-1 env sequences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534408     DOI: 10.1139/o06-143

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  19 in total

Review 1.  Rational development of radiopharmaceuticals for HIV-1.

Authors:  Chuen-Yen Lau; Frank Maldarelli; William C Eckelman; Ronald D Neumann
Journal:  Nucl Med Biol       Date:  2014-01-17       Impact factor: 2.408

2.  Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load.

Authors:  Jessica M Fogel; David Bonsall; Vanessa Cummings; Rory Bowden; Tanya Golubchik; Mariateresa de Cesare; Ethan A Wilson; Theresa Gamble; Carlos Del Rio; D Scott Batey; Kenneth H Mayer; Jason E Farley; James P Hughes; Robert H Remien; Chris Beyrer; Christophe Fraser; Susan H Eshleman
Journal:  J Antimicrob Chemother       Date:  2020-12-01       Impact factor: 5.790

3.  HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005.

Authors:  Mohammed Akrim; Sanae Lemrabet; Elmir Elharti; Rebecca R Gray; Jean Claude Tardy; Robert L Cook; Marco Salemi; Patrice Andre; Taj Azarian; Rajae El Aouad
Journal:  AIDS Res Ther       Date:  2012-02-14       Impact factor: 2.250

4.  Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Authors:  Susan A Fiscus; Susan Cu-Uvin; Abel Tilahun Eshete; Michael D Hughes; Yajing Bao; Mina Hosseinipour; Beatriz Grinsztejn; Sharlaa Badal-Faesen; Joan Dragavon; Robert W Coombs; Ken Braun; Laura Moran; James Hakim; Timothy Flanigan; N Kumarasamy; Thomas B Campbell
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

5.  Positive selection of HIV host factors and the evolution of lentivirus genes.

Authors:  Katarzyna Bozek; Thomas Lengauer
Journal:  BMC Evol Biol       Date:  2010-06-18       Impact factor: 3.260

6.  Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

Authors:  Cagan Gurer; Till Strowig; Fabienne Brilot; Maggi Pack; Christine Trumpfheller; Frida Arrey; Chae Gyu Park; Ralph M Steinman; Christian Münz
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

7.  Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method.

Authors:  Eun-Young Kim; Jennifer Stanton; Bette T M Korber; Kendall Krebs; Derek Bogdan; Kevin Kunstman; Samuel Wu; John P Phair; Chad A Mirkin; Steven M Wolinsky
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

8.  96 shRNAs designed for maximal coverage of HIV-1 variants.

Authors:  Glen John McIntyre; Jennifer Lynne Groneman; Yi-Hsin Yu; Angel Jaramillo; Sylvie Shen; Tanya Lynn Applegate
Journal:  Retrovirology       Date:  2009-06-04       Impact factor: 4.602

9.  Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America.

Authors:  Elena Delgado; Aurora Fernández-García; Marcos Pérez-Losada; María Moreno-Lorenzo; Ismael Fernández-Miranda; Sonia Benito; Vanessa Montero; Horacio Gil; Silvia Hernáez; Josefa Muñoz; Miren Z Zubero-Sulibarria; Elena García-Bodas; Mónica Sánchez; Jorge Del Romero; Carmen Rodríguez; Luis Elorduy; Elena Bereciartua; Esther Culebras; Icíar Rodríguez-Avial; María Luisa Giménez-Alarcón; Carmen Martín-Salas; Carmen Gómez-González; José J García-Irure; Gema Cenzual; Ana Martínez-Sapiña; María Maiques-Camarero; Lucía Pérez-Álvarez; Michael M Thomson
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

10.  HIV-1 proviral landscape characterization varies by pipeline analysis.

Authors:  Fernanda A Ferreira; Qianjing He; Stephanie Banning; Olivia Roberts-Sano; Olivia Wilkins; Daniel R Kuritzkes; Athe Tsibris
Journal:  J Int AIDS Soc       Date:  2021-07       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.